- Home
- BLX vs SDGR Comparison
BLX vs SDGR Comparison
Compare BLX & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLX
- SDGR
- Stock Information
- Founded
- BLX 1977
- SDGR 1990
- Country
- BLX Panama
- SDGR United States
- Employees
- BLX N/A
- SDGR N/A
- Industry
- BLX Commercial Banks
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- BLX Finance
- SDGR Health Care
- Exchange
- BLX Nasdaq
- SDGR Nasdaq
- Market Cap
- BLX 1.6B
- SDGR 1.4B
- IPO Year
- BLX N/A
- SDGR 2020
- Fundamental
- Price
- BLX $45.71
- SDGR $20.61
- Analyst Decision
- BLX
- SDGR Buy
- Analyst Count
- BLX 0
- SDGR 8
- Target Price
- BLX N/A
- SDGR $26.75
- AVG Volume (30 Days)
- BLX 116.7K
- SDGR 1.1M
- Earning Date
- BLX 11-04-2025
- SDGR 11-11-2025
- Dividend Yield
- BLX 5.47%
- SDGR N/A
- EPS Growth
- BLX 12.91
- SDGR N/A
- EPS
- BLX 5.97
- SDGR N/A
- Revenue
- BLX $306,166,000.00
- SDGR $237,917,000.00
- Revenue This Year
- BLX $18.52
- SDGR $22.73
- Revenue Next Year
- BLX $5.81
- SDGR $19.85
- P/E Ratio
- BLX $7.57
- SDGR N/A
- Revenue Growth
- BLX 12.96
- SDGR 18.59
- 52 Week Low
- BLX $31.14
- SDGR $16.60
- 52 Week High
- BLX $48.38
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- BLX 51.35
- SDGR 55.01
- Support Level
- BLX $44.15
- SDGR $18.89
- Resistance Level
- BLX $45.68
- SDGR $22.03
- Average True Range (ATR)
- BLX 0.81
- SDGR 1.11
- MACD
- BLX -0.26
- SDGR -0.03
- Stochastic Oscillator
- BLX 44.09
- SDGR 57.62
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.